Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 10 & 11]

ABSTRACT: Based on differential expression analysis of the transcriptome data and analysis of master regulator genes, we identified 31 candidates which potentially regulate Ca2+-homeostasis in CTL Genes showing differential expression between NK cells and CTL were intersected with members of known Ca2+-signaling pathways and combined with putative key regulators

ORGANISM(S): Homo sapiens

PROVIDER: GSE168691 | GEO | 2021/03/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 6 & 7]

Project description:Based on differential expression analysis of the transcriptome data and analysis of master regulator genes, we identified 31 candidates which potentially regulate Ca2+-homeostasis in CTL Genes showing differential expression between NK cells and CTL were intersected with members of known Ca2+-signaling pathways and combined with putative key regulators

2021-03-11 | GSE168643 | GEO

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 1 & 5]

2021-03-11 | GSE168641 | GEO

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 3 & 4]

2021-03-11 | GSE168686 | GEO

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 9 & 2]

2021-03-11 | GSE168673 | GEO

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 8 & 2, 3, 4]

2021-03-11 | GSE168690 | GEO

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 10 & 11]

Project description:DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 10 & 11]

| PRJNA713509 | ENA

Expression data from control and Phospholipid dependent kinase 1 (PDK1) null cytotoxic T-lymphocytes (CTL) and from control and Akt inhibitor treated CTL

Project description:In cytotoxic T cells (CTL), Protein Kinase B /Akt is activated by the T cell antigen receptor (TCR) and the cytokine Interleukin 2 (IL2), in part by phosophorylation of Akt by Phospholipid dependent kinase 1 (PDK1). The role of PDK1 and Akt in CTL has however not been fully defined. In order to explore the relative roles of these kinases in CTL we used microarrays to profile the gene expression of control and PDK1 null CTL. In separate experiments we compared the gene expression profiles of control and Akt inhibitor treated CTL. CTL were generated from 3 mice each carrying two loxP flanked PDK1 alleles plus a tamoxifen inducible Cre transgene. PDK1 was then deleted from these CTL by tamoxifen treatment and the gene expression pattern determined by microarray. Tamoxifen treated PDK1wt/wt TamoxCre+ CTL generated from 3 PDK1wt/wt TamocCre+ mice were used as a control. In separate experiments CTL were were generated from 3 wild-type mice and then half the CTL generated from each mouse were treated with the Akt inhibitor AktI-1/2. The gene expression patterns of the AktI treated and the untreated CTL were then compared by microarray.

2011-02-01 | E-GEOD-26290 | biostudies-arrayexpress

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Project description:The primary objective of this study is to evaluate the safety of TSA-CTL in the treatment of advanced solid tumors. The secondary objective of this study is to evaluate preliminarily the effect of TSA-CTL in the treatment of advanced solid tumors.

| 2229539 | ecrin-mdr-crc

Expression data from control and Phospholipid dependent kinase 1 (PDK1) null cytotoxic T-lymphocytes (CTL) and from control and Akt inhibitor treated CTL

2011-02-01 | GSE26290 | GEO

DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 9 & 2]

Project description:DEG expression in primary human Cytotoxic T Lymphocytes (CTL, CD8+ T-cells) and Natural Killer cells (NK cells) [donor 9 & 2]

| PRJNA713372 | ENA